Questions

451. Deputy Cormac Devlin asked the Minister for Health if she is aware of the case of a person (details supplied); and if she will seek an update from her officials. [67819/26]

258. Deputy Cormac Devlin asked the Minister for Health the provision being made for women who currently choose and avail of private maternity care in circumstances where there is no private maternity hospital in the State and where private practice is being removed from public maternity hospitals under the public only consultant contract; and if she will make a statement on the matter. [44439/26]

259. Deputy Cormac Devlin asked the Minister for Health if her Department has specifically assessed the position of maternity services, given that the removal of private practice from public hospitals under the public only consultant contract cannot, in the case of maternity care, result in a transfer of that activity to a private setting as no private maternity hospital exists in the State; the steps being taken to …

1283. Deputy Cormac Devlin asked the Minister for Health if she will publish a national clinical pathway for alopecia areata within the HSE Model of Care for Dermatology, covering diagnostic criteria, severity thresholds (for example, SALT scoring), first- and second-line options (including intralesional steroids, topical immunotherapy and JAK inhibitors), vaccination guidance, monitoring schedules and stop rules; an…

1284. Deputy Cormac Devlin asked the Minister for Health the number of public dermatology centres providing topical immunotherapy (for example DPCP or SADBE) for extensive alopecia areata; the number treated in each of the past three years; the average waiting times; and whether capacity expansion is planned; and if she will make a statement on the matter. [30920/26]

1285. Deputy Cormac Devlin asked the Minister for Health to detail the availability of intralesional corticosteroid clinics for patchy alopecia areata, by hospital group; the average wait time from referral; and any actions to standardise access nationally; and if she will make a statement on the matter. [30921/26]

1286. Deputy Cormac Devlin asked the Minister for Health if the HSE will establish a national registry to capture outcomes for alopecia areata (for example, SALT 20 at week 24, durability, relapse), adverse events and service activity; the proposed data controller and governance; and the expected start date; and if she will make a statement on the matter. [30922/26]

1772. Deputy Cormac Devlin asked the Minister for Health if her attention has been drawn to a matter (details supplied); and if she will make a statement on the matter. [18903/26]

1773. Deputy Cormac Devlin asked the Minister for Health the number of patients treated through the diabetes service at St Vincent’s University Hospital in 2024 and to date in 2026; the number of patients with Type 1 diabetes attending the service; and if she will make a statement on the matter. [18904/26]

1774. Deputy Cormac Devlin asked the Minister for Health the level of funding allocated to diabetes services at St Vincent’s University Hospital in each of the years 2024, 2025 and 2026 to date; whether additional funding has been provided to support the expansion of insulin pump therapy and continuous glucose monitoring technologies; and if she will make a statement on the matter. [18905/26]

1775. Deputy Cormac Devlin asked the Minister for Health the number of patients nationally currently supported under the HSE for continuous glucose monitoring technologies including the MiniMed 780G system; whether the Simplera continuous glucose monitoring sensor has been approved for use within the HSE system; whether there are supply or procurement constraints affecting access to such technologies; and if she will…

956. Deputy Cormac Devlin asked the Minister for Health the steps taken to date to implement the guidance issued by an organisation (details supplied) on transparency of medicines pricing and pharmacy service fees, which took effect from 1 December 2025; and to provide an update on early compliance levels, including any monitoring data available to her Department; and if she will make a statement on the matter. [3928…

867. Deputy Cormac Devlin asked the Minister for Health if she is aware of the case of a person (details supplied); to ensure clinical and administrative policies have been followed; if an update will be provided; and if she will make a statement on the matter. [51444/25]

57. Deputy Cormac Devlin asked the Minister for Children, Disability and Equality if she is aware of significant issues with complex care coordination for children with neurological conditions, and that there is a critical need for case management key worker support for children with complex neurological and neurodevelopmental conditions; and if she will make a statement on the matter. [50205/25]

2621. Deputy Cormac Devlin asked the Minister for Health if JAK inhibitor treatments for severe alopecia areata, where reimbursed will be provided via the high tech arrangement; the intended initiation and monitoring setting; the proposed stop rules; the estimated annual budget impact and eligible patient numbers; and if she will make a statement on the matter. [47002/25]

2626. Deputy Cormac Devlin asked the Minister for Health if the HSE will establish a national registry to capture outcomes for alopecia areata (details supplied); the proposed data controller and governance; the expected start date; and if she will make a statement on the matter. [47007/25]

2629. Deputy Cormac Devlin asked the Minister for Health if she will clarify the eligibility of dermatology outpatient consultations for alopecia areata under the Cross-Border Healthcare Directive; the documentation required; whether take-home medicinal products prescribed abroad for alopecia areata are reimbursable under the CBD scheme; and if she will make a statement on the matter. [47014/25]

2631. Deputy Cormac Devlin asked the Minister for Health if she will ensure access to psychological support services for patients with visible hair loss conditions, including alopecia areata and scarring alopecias; the referral pathway from dermatology clinics; the planned service improvements; and if she will make a statement on the matter. [47016/25]

2665. Deputy Cormac Devlin asked the Minister for Health the status of all-island health service collaborations supported by the Shared Island Fund, including the expansion of bespoke all-island services building on paediatric cardiac care, specifying funded capital elements, service start dates and evaluation metrics; and if she will make a statement on the matter. [47402/25]

871. Deputy Cormac Devlin asked the Minister for Health if she is aware of the case of a family (details supplied); if she and the relevant officials from the HSE will engage with this family as a matter of urgency; and if she will make a statement on the matter. [32462/25]